AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2019
Feb 21, 2019
33003_dirs_2019-02-21_9ebd22a2-0239-4c59-b866-430ee0489aff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2019-02-19
Reporting Person: HERSCHA LYNETTE (See Remark)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-19 | Employee Stock Option (Right to Buy) | $8.20 | A | 50000 | Acquired | 2029-02-19 | Common Stock (50000) | Direct |
Footnotes
F1: This option was granted February 19, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19